Recent advances in oncofertility care worldwide and in Japan

AbstractBackgroundOncofertility is a crucial facet of cancer supportive care. The publication of guidelines for the cryopreservation of oocytes and ovarian tissue is becoming increasingly prevalent in Japan and an updated overview is necessary.MethodsIn order to provide an updated overview of oncofertility care, original research and review articles were searched from the PubMed database and compared in order to present clinical care in Japan.ResultsIn Western countries, various methods for ovarian stimulation, such as the combined use of aromatase inhibitors and random‐start protocols, have been reported. Although ovarian tissue cryopreservation, mainly performed via the slow‐freezing method, also has yielded >100 live births, the optimal indications and procedures for the auto‐transplantation of cryopreserved tissue have been under investigation. In Japan, however, vitrification is prevalent for ovarian tissue cryopreservation, although its efficacy has not yet been established. The quality of network systems for providing oncofertility care in Japan varies greatly, based on the region.ConclusionThere remain many issues in the optimization of oncofertility care in Japan. Along with the regional oncofertility networks, the creation of “oncofertility navigators” from healthcare providers who are familiar with oncofertility, such as nurses, psychologists, and embryologists, could be useful for supplementing oncofertility care coordination, overcoming the issues in individual regions.